Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | BHVN | Common Shares | 5.56K | Aug 6, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | BHVN | Employee Stock Option (right to buy) | Aug 6, 2021 | Common Shares | 10K | $71.44 | Direct | F2 | ||||||
holding | BHVN | Employee Stock Option (right to buy) | Aug 6, 2021 | Common Shares | 7K | $83.38 | Direct | F3 | ||||||
holding | BHVN | Employee Stock Option (right to buy) | Aug 6, 2021 | Common Shares | 8.25K | $53.76 | Direct | F4 | ||||||
holding | BHVN | Employee Stock Option (right to buy) | Aug 6, 2021 | Common Shares | 6.71K | $32.42 | Direct | F5 | ||||||
holding | BHVN | Employee Stock Option (right to buy) | Aug 6, 2021 | Common Shares | 1.25K | $30.32 | Direct | F6 | ||||||
holding | BHVN | Restricted Share Unit Award | Aug 6, 2021 | Common Shares | 20K | Direct | F7, F8, F9 | |||||||
holding | BHVN | Restricted Share Unit Award | Aug 6, 2021 | Common Shares | 2.63K | Direct | F7, F9, F10 | |||||||
holding | BHVN | Restricted Share Unit Award | Aug 6, 2021 | Common Shares | 2K | Direct | F7, F9, F11 |
Id | Content |
---|---|
F1 | This balance includes 700 shares and 288 shares that were acquired through the Biohaven Employee Share Purchase Plan on November 30, 2020 and May 31, 2021, respectively, and 200 shares held in an individual retirement account. |
F10 | The reporting person was granted 3,500 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. |
F11 | The reporting person was granted 4,000 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date. |
F2 | The shares underlying this option became exercisable as to 2,500 of these shares on May 7, 2021, with the remainder vesting in 3 equal installments on May 7, 2022, 2023, and 2024, subject to the reporting person's continuing service as of each applicable vesting date. |
F3 | The shares underlying this option became exercisable as to 1,750 of these shares on January 6, 2021, with the remainder vesting in 3 equal installments on January 6, 2022, 2023, and 2024, subject to the reporting person's continuing service as of each applicable vesting date. |
F4 | The shares underlying this option became exercisable as to 3,750 of these shares on and prior to December 5, 2020, with the remainder vesting in 2 equal installments on December 5, 2021, and 2022, subject to the reporting person's continuing service as of each applicable vesting date. |
F5 | The shares underlying this option became exercisable as to 960 of these shares on and prior to November 20, 2020, with the remainder vesting in 2 equal installments on November 20, 2021, and 2022, subject to the reporting person's continuing service as of each applicable vesting date. |
F6 | The shares underlying this option will vest on March 12, 2022, subject to the reporting person's continuing service as of each applicable vesting date. |
F7 | Each restricted share unit represents the contingent right to receive one common share of the Issuer. |
F8 | The reporting person was granted 20,000 restricted share units on May 7, 2021, vesting in four equal installments on May 7, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. |
F9 | Not applicable. |
Exhibit List: Exhibit 24: Power of attorney